Italy: Medicines Agency Open to Hydroxy as a Treatment for Covid-19?

ER Editor: We published the precursor to this story on October 23, 2020 titled Italian Doctors Vow to Keep Using Hydroxy Despite Ban – Petition Launched. Of note:

ER Editor: News website has launched a petition to get the drug hydroxychloroquine officially reinstated so that Italian doctors can once again use it with patients. If not, some of them will go ahead and use it anyway. The retracted Lancet study and trials using lethal doses(!) of HCQ were enough to get it officially banned in Italy as in other countries. Except the Italian Medicines Agency (AIFA) has not yet reapproved it, despite studies showing its effectiveness. Here is the content of the petition translated from Italian:

Covid 19: we ask AIFA (Italian Medicines Agency) to restore the use of hydroxychloroquine

The recent Covid 19 pandemic has made the need for territorial management of the disease manifest. It is now clear to all that in order to win the battle against the virus, it is essential the intervention of the family doctor in the first instance, to activate the necessary diagnostic and therapeutic pathways. …

So will a hydroxychloroquine protocol be permitted by the Italian medicines agency, which would logically compete with a vaccine(s)?

Why is it that those on the ‘right’, typically labelled far right, be open to vaccine alternatives and vaccine choice? France’s Marine Le Pen and a couple of her higher profile party members – Sebastien Chenu and Thierry Mariani – have publicly declared their support for vaccine choice. It is the ‘old shire’ Tories in the UK Parliament who are standing up for basic liberties in relation to lockdown, while the ‘Left’ everywhere is advocating coercion on the public.


Italy: first opening of Aifa to hydroxychloroquine as a treatment for Covid-19


According to Matteo Salvini, former Italian Deputy Prime Minister and Minister of the Interior, the AIFA Italian pharmaceutical agency could give the green light to a new antimalarial protocol applied to Covid at the next board meeting. In the meantime, the case is back in the administrative court of Lazio.

“I understand that the Italian Medicines Agency, in the next few days, will meet its board of directors to approve an experimental protocol on hydroxychloroquine”. This was announced by Matteo Salvini on Porta a Porta (ER: TV show) on November 12. The leader of the League said that “what is requested is to make an experimental protocol that was suspended in May” by the AIFA for the treatment of Covid-19, given that “doctors must be free to choose the treatments, they must know what treatments they can administer”.

This comes almost a month after Panorama launched the petition on the website, which explained that a number of doctors were going to use hydroxychloroquine.




The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)


Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.


Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.


Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.